Marksans Pharma rallied 5 percent on Monday as the company entered into a settlement agreement with the holders of foreign currency convertible bonds (FCCBs) for settling USD 26,918,000 worth of FCCBs in principal value.
At 14:14 hours IST, shares were quoting at Rs 3.99 amid high volumes on Bombay Stock Exchange.
There were pending buy orders of 22,709 shares, with no sellers available.
Trading volumes increased 47 percent to 6,23,421 equity shares as against five-day average of 4,22,193 shares.
Market capitalisation of the company currently stands at Rs 153.74 crore.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
